Table 1 Site-wise distribution of cases before and during COVID period
Site of cancer | Group A before COVID period (April 2019–April 2020) | Group B COVID period (May 2020–May 2021) | Change (%) for site between two time periods | ||
|---|---|---|---|---|---|
Number | Percentage | Number | Percentage | ||
Breast | 180 | 18.76 | 105 | 17.01 | -26.32 |
Others | 70 | 7.29 | 37 | 5.99 | -30.84 |
Thorax | 5 | 0.52 | 4 | 0.64 | -11.11 |
GIT | 207 | 21.58 | 151 | 24.47 | -15.64 |
Head and neck | 340 | 35.45 | 197 | 31.92 | -26.63 |
Gynecology | 125 | 13.03 | 77 | 12.47 | -23.76 |
Male genital and urinary system | 32 | 3.33 | 24 | 3.88 | -14.29 |
Total | 959 | 100 | 617 | 100 | -21.70 |
Chi-square test | 11.87 | ||||
p-value | 0.044* | ||||